Jim Riley

Jim Riley

University of Pennsylvania

H-index: 80

North America-United States

About Jim Riley

Jim Riley, With an exceptional h-index of 80 and a recent h-index of 49 (since 2020), a distinguished researcher at University of Pennsylvania, specializes in the field of Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication

Targeting t regulatory cells to islet cells to stall or reverse type 1 diabetes

Crosstalk between histone and DNA methylation in the development and progression of ALK+ ALCL

Mitochondrial cristae disruption enables optimal T cell activation and expansion

Methods to protect transplanted tissue from rejection

Expansion of populations of T cells by the use of modified serum free media

Sequential Exposure to IL21 and IL15 During Human Natural Killer Cell Expansion Optimizes Yield and Function

Anti-cd3 scfv and cytokine producing artificial antigen presenting cells

Jim Riley Information

University

Position

___

Citations(all)

30800

Citations(since 2020)

11624

Cited By

23941

hIndex(all)

80

hIndex(since 2020)

49

i10Index(all)

140

i10Index(since 2020)

115

Email

University Profile Page

University of Pennsylvania

Google Scholar

View Google Scholar Profile

Jim Riley Skills & Research Interests

Immunology

Top articles of Jim Riley

Title

Journal

Author(s)

Publication Date

CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication

The Journal of clinical investigation

Pablo Tebas

Julie K Jadlowsky

Pamela A Shaw

Lifeng Tian

Erin Esparza

...

2021/4/1

Targeting t regulatory cells to islet cells to stall or reverse type 1 diabetes

2024/4/25

Crosstalk between histone and DNA methylation in the development and progression of ALK+ ALCL

Cancer Research

Cosimo Lobello

Shengchun Wang

Shilpa Rao

Jan Pawlicki

Nashwa Mansoor

...

2024/3/22

Mitochondrial cristae disruption enables optimal T cell activation and expansion

The Journal of Immunology

Irene Su

Christopher Ecker

Sriram Srivatsa

James Riley

2023/5/1

Methods to protect transplanted tissue from rejection

2023/11/28

Expansion of populations of T cells by the use of modified serum free media

2023/3/7

Sequential Exposure to IL21 and IL15 During Human Natural Killer Cell Expansion Optimizes Yield and Function

Cancer Immunology Research

Caimei Zhang

Siddhant Kadu

Yansen Xiao

Omar Johnson

Andre Kelly

...

2023/11/1

Anti-cd3 scfv and cytokine producing artificial antigen presenting cells

2023/1/5

Improved generation of lentiviral vectors for t cell transduction using cocal envelope

2023/10/12

Aberrant expression of GOLM1 protects ALK+ anaplastic large cell lymphoma from apoptosis by enhancing BCL-XL stability

Blood Advances

Zhenguo Zi

Shujuan Du

Liming Zhang

Yuebo Wang

Ling Ding

...

2023/8/8

Augmenting TCR signal strength and ICOS costimulation results in metabolically fit and therapeutically potent human CAR Th17 cells

Molecular Therapy

Megan M Wyatt

Logan W Huff

Michelle H Nelson

Lillian R Neal

Andrew R Medvec

...

2023/7/5

Icos critically regulates the expansion and function of inflammatory human th17 cells

2023/12/14

Trafficking and persistence of alloantigen-specific chimeric antigen receptor regulatory T cells in Cynomolgus macaque

Cell Reports Medicine

Gavin I Ellis

Kimberly E Coker

Delaine W Winn

Mosha Z Deng

Divanshu Shukla

...

2022/5/17

Alloantigen-specific Chimeric Antigen Receptor Regulatory T cell therapy in non-human primate islet transplantation

The Journal of Immunology

Gavin I Ellis

Kimberly E Coker

Delaine W Winn

Mosha Z Deng

Divanshu Shukla

...

2022/5/1

A BW6 Specific CAR Designed To Protect Transplanted Tissue From Rejection

2022/3/24

Generation of non-human primate CAR Tregs using artificial antigen-presenting cells, simian tropic lentiviral vectors, and antigen-specific restimulation

STAR protocols

Gavin I Ellis

Mosha Z Deng

Delaine W Winn

Kimberly E Coker

Divanshu Shukla

...

2022/12/16

Engineering T cells to survive and thrive in the hostile tumor microenvironment

Gloria B Kim

James L Riley

Bruce L Levine

2022/3/1

HIV-1–Infected CD4+ T Cells Present MHC Class II–Restricted Epitope via Endogenous Processing

The Journal of Immunology

Mary M Addison

Gavin I Ellis

George J Leslie

Noah B Zawadzky

James L Riley

...

2022/9/1

CD64 GENE-MODIFIED PRIMARY NK CELLS LOADED with ANTI-HIV bNAbs TRIGGER HIGH ADCC

Topics in Antiviral Medicine

C Tomescu

H Kong

M Lai

JL Riley

LJ Montaner

2022

Quantitative immunopeptidomics reveals a tumor stroma–specific target for T cell therapy

Science translational medicine

Gloria B Kim

Jens Fritsche

Sebastian Bunk

Andrea Mahr

Felix Unverdorben

...

2022/8/31

See List of Professors in Jim Riley University(University of Pennsylvania)